BARTOLUCCI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 348
EU - Europa 215
AS - Asia 143
Continente sconosciuto - Info sul continente non disponibili 1
Totale 707
Nazione #
US - Stati Uniti d'America 339
IE - Irlanda 112
CN - Cina 96
IT - Italia 63
SG - Singapore 22
DE - Germania 10
IR - Iran 10
CA - Canada 9
FI - Finlandia 7
FR - Francia 6
HK - Hong Kong 5
MY - Malesia 5
SE - Svezia 5
BE - Belgio 4
CZ - Repubblica Ceca 4
GR - Grecia 2
JP - Giappone 2
EU - Europa 1
GB - Regno Unito 1
IN - India 1
NL - Olanda 1
TR - Turchia 1
TW - Taiwan 1
Totale 707
Città #
Dublin 112
Chandler 106
Boardman 35
Shanghai 23
Ashburn 18
Lawrence 15
Medford 15
Princeton 15
Beijing 14
Pavia 14
Singapore 13
Dearborn 12
Ann Arbor 8
Jiaxing 8
Nanjing 8
Shenyang 8
Helsinki 7
Nanchang 7
Changsha 6
Dezful 6
Toronto 6
Wilmington 6
Brno 4
Brussels 4
Cagliari 4
Hangzhou 4
Hebei 4
Milan 4
New York 4
Fairfield 3
Jacksonville 3
Seattle 3
Stezzano 3
Tianjin 3
Castano Primo 2
Genoa 2
Hefei 2
Kowloon 2
Novara 2
Ottawa 2
Romano di Lombardia 2
Shijiazhuang 2
Tehran 2
Tokyo 2
Aosta 1
Athens 1
Atlanta 1
Bareggio 1
Dallas 1
Falkenstein 1
Fuzhou 1
Heemskerk 1
Hong Kong 1
Kashan 1
Kish 1
Kunming 1
Los Angeles 1
Modena 1
Nagold 1
Navi Mumbai 1
Ningbo 1
Norwalk 1
Piscataway 1
Rockville 1
Sacramento 1
San Francisco 1
Santa Clara 1
Shaoxing 1
Taipei 1
Vaiano Cremasco 1
Washington 1
Winnipeg 1
Zhengzhou 1
Totale 554
Nome #
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 67
Whole-body PBPK model for a translational study of Azathioprine pharmacokinetics 61
A PBPK model for the study of Azathioprine pharmacokinetics in rats and prediction in humans 60
Predicting Aqueous and Intrinsic Solubility of Pharmaceutical Molecules with Neural Networks 56
Artificial intelligence and machine learning: just a hype or a new opportunity for pharmacometrics? 51
Development of a PBPK model for the study of Azathioprine pharmacokinetics in rats and translation to humans 50
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension 43
Optimal design in pediatric clinical trials: theory and application to the macitentan case study 36
Optimal design of paediatric clinical trials: the Macitentan case study 35
A genetic algorithm for covariate selection 35
Modeling approaches for reducing safety-related attrition in drug discovery and development: a review on myelotoxicity, immunotoxicity, cardiovascular toxicity, and liver toxicity 35
Application of Artificial Neural Networks to Predict the Intrinsic Solubility of Drug-Like Molecules 34
Optimization of the sampling strategy for pediatric clinical trials: the importance of prior information 34
Development of a genetic algorithm for covariate analysis in population pharmacokinetic models 34
PKPD modelling of MEN1611 anti-tumor effect in xenograft models to predict efficacy threshold concentrations in HER2-positive advanced or metastatic breast cancer patient population 32
Facing the limits of the genetic algorithms for covariate selection 31
How Modelling and Simulations combined with Artificial Intelligence can improve Precision Dosing 27
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients 8
A clinical trial simulator to predict the effect of an adaptive dosing regimen of an investigated compound on platelets, white blood cells and haematocrit in patients with Polycythemia Vera 8
Go beyond the limits of genetic algorithm in daily covariate selection practice 7
Totale 744
Categoria #
all - tutte 3.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 3 5 3 1 6 3 0
2020/202114 0 0 0 0 1 1 1 5 1 1 0 4
2021/202289 2 1 5 1 2 3 0 14 6 4 15 36
2022/2023299 28 29 2 15 26 23 2 24 125 0 8 17
2023/2024167 13 43 4 4 14 20 30 9 3 3 4 20
2024/202563 11 33 2 3 10 4 0 0 0 0 0 0
Totale 744